Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Free Cash Flow: 2021-2025

Historic Free Cash Flow for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$3.8 million.

  • Biofrontera's Free Cash Flow fell 202.71% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year increase of 34.31%. This contributed to the annual value of -$10.3 million for FY2024, which is 58.60% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Free Cash Flow is -$3.8 million, which was down 23.18% from -$3.1 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Free Cash Flow registered a high of $81,000 during Q2 2022, and its lowest value of -$21.0 million during Q4 2021.
  • In the last 3 years, Biofrontera's Free Cash Flow had a median value of -$3.7 million in 2023 and averaged -$4.2 million.
  • As far as peak fluctuations go, Biofrontera's Free Cash Flow skyrocketed by 107.61% in 2022, and later slumped by 12,846.91% in 2023.
  • Biofrontera's Free Cash Flow (Quarterly) stood at -$21.0 million in 2021, then skyrocketed by 60.60% to -$8.3 million in 2022, then dropped by 7.12% to -$8.9 million in 2023, then soared by 89.17% to -$960,000 in 2024, then slumped by 202.71% to -$3.8 million in 2025.
  • Its Free Cash Flow stands at -$3.8 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$4.1 million for Q1 2025.